Abstract | PURPOSE: PATIENTS AND METHODS: RESULTS: With 7 years of follow-up, DFS remained similar between treatment arms (hazard ratio [HR], 0.740; 95% CI, 0.520 to 1.050; P=.0922). OS also was similar (HR, 1.130; 95% CI, 0.775 to 1.647; P=.5272). The effect of the addition of radiotherapy on DFS and OS differed by Lauren classification (interaction P=.04 for DFS; interaction P=.03 for OS) and lymph node ratio (interaction P<.01 for DFS; interaction P<.01 for OS). Subgroup analyses also showed that chemoradiotherapy significantly improved DFS in patients with node-positive disease and with intestinal-type GC. There was a similar trend for DFS and OS by stage of disease. CONCLUSION:
|
Authors | Se Hoon Park, Tae Sung Sohn, Jeeyun Lee, Do Hoon Lim, Min Eui Hong, Kyoung-Mee Kim, Insuk Sohn, Sin Ho Jung, Min Gew Choi, Jun Ho Lee, Jae Moon Bae, Sung Kim, Seung Tae Kim, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang |
Journal | Journal of clinical oncology : official journal of the American Society of Clinical Oncology
(J Clin Oncol)
Vol. 33
Issue 28
Pg. 3130-6
(Oct 01 2015)
ISSN: 1527-7755 [Electronic] United States |
PMID | 25559811
(Publication Type: Clinical Trial, Phase III, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2015 by American Society of Clinical Oncology. |
Chemical References |
|
Topics |
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Capecitabine
(adverse effects, therapeutic use)
- Chemoradiotherapy, Adjuvant
(adverse effects, mortality)
- Chemotherapy, Adjuvant
- Cisplatin
(adverse effects, therapeutic use)
- Disease-Free Survival
- Female
- Gastrectomy
(adverse effects, mortality)
- Humans
- Kaplan-Meier Estimate
- Lymph Node Excision
- Male
- Middle Aged
- Neoplasm Staging
- Proportional Hazards Models
- Republic of Korea
- Stomach Neoplasms
(mortality, pathology, therapy)
- Time Factors
- Treatment Outcome
- Young Adult
|